{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:28:46Z","timestamp":1790875726453,"version":"4.1.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We evaluated trends in non-Lyme disease tick-borne disease (NLTBI) testing at a national reference laboratory.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Testing data performed at Quest Diagnostics during 2010 to 2016 were analyzed nationally and at the state level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Testing and positivity for most NLTBIs increased dramatically from 2010 through 2016 based on testing from a large reference laboratory. The number of positive cases, though not as stringent as criteria for public health reporting, generally exceeds that reported by the Centers for Disease Control and Prevention. The frequency of NLTBI in the US is seasonal but testing activity and positive test results are observed throughout all months of the year. Positive results for NLTBI testing mostly originated from a limited number of states, indicating the geographic concentration and distribution of NLTBIs reported in this study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This report provides an important complementary source of data to best understand trends in and spread of NLTBI.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ajcp\/aqz139","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T19:16:23Z","timestamp":1563995783000},"page":"139-145","source":"Crossref","is-referenced-by-count":6,"title":["Laboratory Blood-Based Testing for Non-Lyme Disease Tick-Borne Infections at a National Reference Laboratory"],"prefix":"10.1093","volume":"153","author":[{"given":"Elizabeth","family":"Lee-Lewandrowski","sequence":"first","affiliation":[{"name":"Department of Pathology, Division of Clinical Laboratories and Molecular Medicine, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[{"name":"Quest Diagnostics, Secaucus, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Branda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Clinical Laboratories and Molecular Medicine, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Baron","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Clinical Laboratories and Molecular Medicine, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey W","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Quest Diagnostics, Secaucus, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"2019121321380871600_CIT0001","author":"Centers for Disease Control and Prevention"},{"key":"2019121321380871600_CIT0002","unstructured":"Commonwealth of Massachusetts. Lyme disease. http:\/\/www.mass.gov\/eohhs\/gov\/departments\/dph\/programs\/id\/epidemiology\/ticks\/public-health-cdc-tickborne-lyme-faq.html#2. Accessed December 8, 2017."},{"key":"2019121321380871600_CIT0003","doi-asserted-by":"crossref","first-page":"496","DOI":"10.15585\/mmwr.mm6717e1","article-title":"Vital signs: trends in reported vectorborne disease cases-United States and territories, 2004-2016","volume":"67","author":"Rosenberg","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"2019121321380871600_CIT0004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajcp\/aqy067","article-title":"Laboratory testing for tick-borne infections in a large northeastern academic medical center: an 11-year experience","volume":"150","author":"Rudolf","year":"2018","journal-title":"Am J Clin Pathol."},{"key":"2019121321380871600_CIT0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin Infect Dis."},{"key":"2019121321380871600_CIT0006","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1017\/S0950268818001395","article-title":"Q fever: an under-reported reportable communicable disease","volume":"146","author":"Kaufman","year":"2018","journal-title":"Epidemiol Infect."},{"key":"2019121321380871600_CIT0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ajcp\/aqz030","article-title":"Laboratory blood-based testing for Lyme disease at a national reference laboratory","volume":"152","author":"Lee-Lewandrowski","year":"2019","journal-title":"Am J Clin Pathol."},{"key":"2019121321380871600_CIT0008","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9343(99)00046-7","article-title":"Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States","volume":"106","author":"Hilton","year":"1999","journal-title":"Am J Med."},{"key":"2019121321380871600_CIT0009","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/vbz.2016.2020","article-title":"Seroprevalence of Babesia microti in individuals with Lyme disease","volume":"16","author":"Curcio","year":"2016","journal-title":"Vector Borne Zoonotic Dis."},{"key":"2019121321380871600_CIT0010","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1196\/annals.1374.042","article-title":"Clinical diagnosis and treatment of human granulocytotropic anaplasmosis","volume":"1078","author":"Bakken","year":"2006","journal-title":"Ann NY Acad Sci."},{"key":"2019121321380871600_CIT0011","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/CDLI.8.1.199-202.2001","article-title":"Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay","volume":"8","author":"Brouqui","year":"2001","journal-title":"Clin Diagn Lab Immunol."},{"key":"2019121321380871600_CIT0012","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0025-7125(03)00093-2","article-title":"Human ehrlichioses","volume":"86","author":"Olano","year":"2002","journal-title":"Med Clin North Am."},{"key":"2019121321380871600_CIT0013","author":"Centers for Disease Control and Prevention"},{"key":"2019121321380871600_CIT0014","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4269\/ajtmh.13-0180","article-title":"Meteorological influences on the seasonality of Lyme disease in the United States","volume":"90","author":"Moore","year":"2014","journal-title":"Am J Trop Med Hyg."},{"key":"2019121321380871600_CIT0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fphys.2012.00064","article-title":"Impact of climate trends on tick-borne pathogen transmission","volume":"3","author":"Estrada-Pe\u00f1a","year":"2012","journal-title":"Front Physiol."},{"key":"2019121321380871600_CIT0016","first-page":"590","article-title":"Recommendations for test performance and interpretation from the Second National Conference on serologic diagnosis of Lyme disease","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":". MMWR Morb Mortal Wkly Rep."},{"key":"2019121321380871600_CIT0017","author":"Mayo Clinic Laboratories"},{"key":"2019121321380871600_CIT0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","article-title":"Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States","volume":"65","author":"Biggs","year":"2016","journal-title":"MMWR Recomm Rep."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/153\/1\/139\/31516374\/aqz139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/153\/1\/139\/31516374\/aqz139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T06:53:06Z","timestamp":1610607186000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/153\/1\/139\/5581519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,10,4]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqz139","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,10,4]]}}}